 EDEN PRAIRIE, Minn., Nov. 03, 2022 GLOBE NEWSWIRE -- Miromatrix Medical Inc. NASDAQ: MIRO, a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients lives, today announced that the Company will report financial results for the third quarter 2022 after market close on Monday, November 14, 2022. Company management will host a corresponding conference call beginning at 3:30 pm Central Time 4:30 pm Eastern Time. 